The Patient pp 401-418 | Cite as

Drugs That Affect Behavior

  • Hoyle Leigh
  • Morton F. Reiser


Antipsychotic Drug Biogenic Amine Tardive Dyskinesia Antipsychotic Agent Lithium Salt 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


Recommended Reading

  1. Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. New York, Macmillan, 1980.Google Scholar
  2. Hansten PD: Drug Interactions. Philadelphia, Lea & Febiger, 1976.Google Scholar
  3. Jarvik ME (ed): Psychopharmacology in the Practice of Medicine. New York, Appleton-CenturyCrofts, 1977.Google Scholar
  4. Lipton MA, DiMascio A, Killam KF (ed): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978.Google Scholar


  1. Boston Collaborative Drug Surveillance Program report: Adverse reactions to the tricyclic antidepressant drugs. Lancet 1: 529–31, 1972.Google Scholar
  2. Baldessanni RJ, Lipinski JF: Lithium salts: 1970–1975. Ann Intern Med 83: 527–533, 1975.Google Scholar
  3. Blackwell B: Drug therapy: Patient compliance. N Engl J Med 289: 249–252, 1973.PubMedCrossRefGoogle Scholar
  4. Charney DS, Menkes, DB, Heninger GR: Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 38: 1160–1180, 1981PubMedCrossRefGoogle Scholar
  5. Charney DS, Heninger GR, Sternberg DE, et al.: Presynaptic adrenergic receptor sensitivity in depression: The effect of long-term desipramine treatment. Arch Gen Psychiatry 38:1334–1340, 1981Google Scholar
  6. De Montigny C, Grunberg F, Mayer A, et al.: Lithium induces rapid relief of depression in tricyclic antidepressant drug nonresponders. Br J Psychiatry 138:252–256, 1981.Google Scholar
  7. Gerbino L, Oleshansky M, Gershon S: Clinical use and mode of action of lithium, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 1261–1275.Google Scholar
  8. Goodwin FK, Ebert MH: Lithium in mania, in Gershon S, Shopsin B (eds): Lithium: Its Role in Psychiatric Research and Treatment. New York, Plenum Press, 1973, pp 237–252.Google Scholar
  9. Hoehn-Saric R: Neurotransmitters in anxiety. Arch Gen Psychiatry 39: 735–742, 1982.PubMedCrossRefGoogle Scholar
  10. Holden C: Cancer and the mind: How are they connected? Science 200: 1369, 1978.CrossRefGoogle Scholar
  11. Hollister LE: Second generation antidepressant drugs. Psychosomatics 22: 872–879, 1981.PubMedGoogle Scholar
  12. Kantor SJ, Glassman AH, Bigger JT, et al.: The cardiac effects of therapeutic plasma con-centrations of imipramine. Am J Psychiatry 135:534–538, 1978.Google Scholar
  13. Klopfer B: Psychological variables in human cancer. J Project Tech 21: 331–334, 1957.CrossRefGoogle Scholar
  14. Maas JW: Clinical implications of pharmacological differences among antidepressants, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 955–960.Google Scholar
  15. Mazzullo J: The nonpharmacologic basis of therapeutics. Clin Pharmacol Ther 13: 157–158, 1972.PubMedGoogle Scholar
  16. Robinson DS, Nies A, Ravaris CL, et al: Clinical pharmacology of phenelzine. Arch Gen Psychiatry 35: 629–635, 1978.PubMedCrossRefGoogle Scholar
  17. Rosenbaum J: The drug treatment of anxiety. N Engl J Med 306: 401–404, 1982.PubMedCrossRefGoogle Scholar
  18. Singer I, Rotenberg D: Mechanisms of lithium action. N Engl J Med 289: 254–260, 1973.PubMedCrossRefGoogle Scholar
  19. Snyder SH: Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 34: 236–239, 1977.PubMedCrossRefGoogle Scholar
  20. Snyder SH, Enna SJ, Young AB: Brain mechanisms associated with therapeutic actions of benzodiazepines: Focus on neurotransmitters. Am J Psychiatry 134: 662–665, 1977.PubMedGoogle Scholar
  21. Squires RF, Braestrup C: Benzodiazepine receptors in rat brain. Nature (London) 266: 732–734, 1977.CrossRefGoogle Scholar
  22. Stein L, Belluzzi JD, Wise CD: Benzodiazepines: Behavioral and neurochemical mechanisms. Am J Psychiatry 134: 665–669, 1977.PubMedGoogle Scholar

Copyright information

© Hoyle Leigh and Morton F. Reiser 1985

Authors and Affiliations

  • Hoyle Leigh
    • 1
    • 2
  • Morton F. Reiser
    • 3
  1. 1.Yale University School of MedicineYale-New Haven HospitalNew HavenUSA
  2. 2.Psychiatric Consultation-Liaison and Outpatient ServicesYale-New Haven HospitalNew HavenUSA
  3. 3.Department of PsychiatryYale University School of MedicineNew HavenUSA

Personalised recommendations